GSK1292263 T2701
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
GSK1292263 is a GPR119 agonist and has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
CAS nr:
1032823-75-8
Purity:
98%
Molecular Weight:
456,56
SMILES:
o1nc(nc1N1CCC(CC1)COc1cnc(cc1)c1ccc(cc1)S(=O)(=O)C)C(C)C
Formula:
C23H28N4O4S
Pathway:
Endocrinology/Hormones,GPCR/G Protein
Target:
GPR,GPR
